Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07024719 · ClinicalTrials.gov registry record · NA
4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800
A NA study of Retinal Diseases and Corneal Diseases, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT07024719 is a NA study of Retinal Diseases and Corneal Diseases that is actively recruiting participants, run by Duke University. The registered enrollment target is 5 participants, below the 396-participant average among 8 other Retinal Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07024719, a NA study of Retinal Diseases and Corneal Diseases, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team will conduct the first in-human pilot studies using 4D MIOCT for imaging in the operating room. Building on the earlier integration and wet-lab validations, the researchers will assess the system's ease of use, safety, and visualization of intended structures during various anterior and posterior segment ophthalmic procedures.
Conditions Studied
Interventions
- DEVICE 4D MIOCT integrated into a Zeiss Artevo 800
Study Locations (1)
North Carolina
- Duke University Eye Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-07-24 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07024719
The ClinicalTrials.gov registry entry for NCT07024719 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 396-participant average among 8 other Retinal Diseases trials with a reported enrollment target (99% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Retinal Diseases appearing as the primary indexed condition, and to 1 intervention - of which 4D MIOCT integrated into a Zeiss Artevo 800 is the first listed.
NCT07024719 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07024719 about?
NCT07024719 is a clinical study titled "4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800". The study team will conduct the first in-human pilot studies using 4D MIOCT for imaging in the operating room. Building on the earlier integration and wet-lab validations, the researchers will assess the system's ease of use, safety, and visualization of intended structures during various anterior a...
What is the current status of trial NCT07024719?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-07-24. Estimated completion is 2026-10.
What conditions does trial NCT07024719 study?
This clinical trial studies the following conditions: Retinal Diseases, Corneal Diseases, Ocular Diseases.
What interventions are being tested in trial NCT07024719?
The interventions under investigation include: 4D MIOCT integrated into a Zeiss Artevo 800 (DEVICE).
Who is sponsoring clinical trial NCT07024719?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07024719 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DISCOVER Study: Microscope-integrated Intraoperative OCT Study
RECRUITING
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations
ACTIVE NOT RECRUITING · Phase 1
-
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
ACTIVE NOT RECRUITING
-
Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD
COMPLETED · Phase 3
-
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.